Science
Enabling focused development through complement biology
A targeted complement modulation platform
Complement Therapeutics has developed a platform focused on targeted modulation of the complement system for ocular disease. The platform is designed to enable precise intervention within complex biological pathways, informed by disease mechanism and clinical relevance.
This approach supports the generation of focused programmes with defined biological rationale and development potential.
Platform design principles
The platform is underpinned by key design principles, including biological specificity, translational alignment, and development discipline. Programme selection and progression are informed by mechanistic insight, data quality, and patient relevance.
These principles guide decision-making across discovery, preclinical development, and clinical translation.
Supporting a focused pipeline
Complement’s platform enables the development of a focused pipeline addressing clearly defined disease mechanisms. By maintaining alignment between platform capabilities and clinical objectives, the company supports efficient progression toward clinical evaluation.
Explore our research and development programmes or contact the team regarding scientific collaboration, partnerships, or general enquiries.
